Cytokines and growth factors regulate growth, differentiation, and activation across lymphocytes, mast cells, endothelial cells, and beyond. This section covers interleukins, interferons, chemokines, the TNF superfamily, colony-stimulating factors, and growth factor families such as TGF-β, VEGF, EGF, and FGF—supporting immunology, cell biology, and drug discovery.
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
| Catalog # | Product / Synonym | Species | Expression | Protein structure |
|---|---|---|---|---|
| LILRB1-HP002 | Human | Human; HEK293; Recombinant Human LILRB1/CD85j/ILT2 Protein is expressed in HEK293 cells with a His tag at the C-terminus. It contains amino acid residues Leu116-Val461 (UniProt accession: Q8NHL6-1). | LILRB1/CD85j/ILT2His N-terminusC-terminus AA segmentLeu116-Val461 | |
| LILRB1-CP004 | Cynomolgus | Cynomolgus; HEK293; Recombinant Cynomolgus LILRB1/CD85j/ILT2 Protein is expressed in HEK293 cells with a His tag at the C-terminus. It contains amino acid residues Gly41-His474 (accession: XP_045236898.1). | LILRB1/CD85j/ILT2His N-terminusC-terminus AA segmentGly41-His474 | |
| KRASWT-HP007 | Human | Human; HEK293; Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and VVVGAGGVGK peptide | HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASWT-HB002 | Human | Human; HEK293; Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and VVVGAGGVGK peptide | HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASG12V-HB008 | Human | Human; HEK293; Gly25-Thr305 (HLA-A*11:01), Ile21-Met119 (B2M) and VVVGAVGVGK peptide | HLA-A*11:01&B2M&KRAS G12V (VVVGAVGVGK) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASG12V-HB004 | Human | Human; HEK293; Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and VVGAVGVGK peptide | HLA-A*11:01&B2M&KRAS G12V (VVGAVGVGK) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASG12R-HP002 | Human | Human; HEK293; Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and VVVGARGVGK peptide | HLA-A*11:01&B2M&KRAS G12R (VVVGARGVGK) TetramerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASG12R-HB001 | Human | Human; HEK293; Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M)and VVVGARGVGK peptide | HLA-A*11:01&B2M&KRAS G12R (VVVGARGVGK) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASG12D-HP019 | Human | Human; HEK293; Cys25-Ala366(HLA-C*05:01), Ile21-Met119(B2M) and GADGVGKSAL peptide | PE-Labeled Human HLA-C*05:01&B2M&KRAS G12D (GADGVGKSAL) TetramerAviHis N-terminusC-terminus AA segmentCys25-Ala366 | |
| KRASG12D-HP014 | Human | Human; HEK293; Gly25-Thr305(HLA-A*03:01), Ile21-Met119(B2M) and VVVGADGVGK peptide | APC-Labeled Human HLA-A*03:01&B2M&KRAS G12D (VVVGADGVGK) TetramerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASG12D-HP006 | Human | Human; HEK293; Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and VVVGADGVGK peptide | HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) TetramerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASG12C-HP005 | Human | Human; HEK293; Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and VVVGACGVGK peptide | HLA-A*11:01&B2M&KRAS G12C (VVVGACGVGK) TetramerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASG12C-HB001 | Human | Human; HEK293; Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M)and VVVGACGVGK peptide | HLA-A*11:01&B2M&KRAS G12C (VVVGACGVGK) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASG12A-HB001 | Human | Human; HEK293; Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M)and VVVGAAGVGK peptide | HLA-A*11:01&B2M&KRAS G12A (VVVGAAGVGK) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| HLAE0103-HP004 | Human | Human; HEK293; Gly22-Thr302(HLA-E*01:03) & Ile21-Met119(B2M) | Peptide Ready HLA-E*01:03&B2M MonomerAviHis N-terminusC-terminus AA segmentGly22-Thr302 | |
| GPRC5D-HB001 | Human | Recombinant Biotinylated Human GPRC5D VLP is expressed from HEK293. It contains Met1-Val345 (It may have cross reaction with anti-His antibody) (accession: Q9NZD1-1). | GPRC5D VLPHis N-terminusC-terminus AA segmentMet1-Val345 | |
| FCRN-AB001 | Human | Human/Cynomolgus/Rhesus macaque; HEK293; Human IgG1-Kappa | Anti-FcRnCore N-terminusC-terminus | |
| CD3ED-HP001 | Human | Human; HEK293; Recombinant Human CD3E&CD3D/CD3 epsilon&CD3 delta Protein is expressed in HEK293 cells with a His tag at the C-terminus of CD3D. It contains amino acid residues Asp23-Asp126 (CD3E) and Phe22-Ala105 (CD3D) (accession: P07766(CD3E) & P04234(CD3D)). | CD3E&CD3D/CD3 epsilon&CD3 deltaHis N-terminusC-terminus AA segmentAsp23-Asp126 | |
| CD32A-HP003 | Human | Human; HEK293; Recombinant Human Fc gamma RIIA/CD32a (R167) Protein is expressed in HEK293 cells with a His tag and Avi tag at the C-terminus. It contains amino acid residues Gln34-Ile218(R167) (UniProt accession: P12318-1). | Non-biotinylated Human Fc gamma RIIA/CD32a (R167)AviFcHis N-terminusC-terminus AA segmentGln34-Ile218 | |
| BAFFR-AB001 | Human | Human/Cynomolgus/Rhesus macaque; HEK293; Human IgG1-Kappa | Anti-BAFFRCore N-terminusC-terminus |
